FYBOGEL LEMON

Active substance: ISPAGHULA HUSK

View full screen / Print PDF » Download PDF ⇩

Transcript
Customer:
Reckitt & Colman
Product Description:
Lemon Laminate UK/Ire
TAS Reference:
RC149704
Date:
20/07/99
Action:
C/Handover
Printer:
Lawson Mardon
Print Process:
Gravure
Artwork Dimensions:
179mm (h) v 70mm (v)
Extra Info/Notes:
Substrate:
Foil with a paper laminate

Reckitt Benckiser
Reckitt Benckiser Healthcare (UK) Ltd.

Coding Area
Substrate
How to use Fybogel Lemon:
w
Fybogel
To make a pleasant lemon high fibre drink briskly stir the
o make
drink briskly
sachet contents into a glass of cold water (approx 150ml
water (approx
1/4 pint) and dr
or
drink straight away, preferably after a meal.
aight a
, pref
Dosage:
Adults and children o
hildren over 12: one sachet in the mor
morning
and one in the e ening, or as prescribed by your doctor.
evening,
prescr
Children 6 - 12: 1/2 - 1 level 5ml spoonful, mor
el
morning and
evening, depending on age and siz
ening,
size.
Children under 6 year to be taken only on medical
ears:
taken
advice, 1/2 - 1 level 5ml spoonful, depending on age and
el
size, morning and evening.
ning
e ening.
Each sachet of Fybogel Lemon g
granules contains: 3.5g of
aspar
Ispaghula Husk BP in a base containing aspartame and
bicarbonate
potassium bicarbonate.
Keep all medicines out of the reach of children. Do not
eep
reac
Fybogel
take more Fybogel Lemon than directed.
Store dry below 30˚C
y below 30
Contains 1 dose

UK PL 0063/0024
MA Holder:
Holder
Reckitt Benckiser Healthcare (UK) Ltd.,
Hull, HU8 7DS.
7DS

Fybogel Lemon and

CODING
AREA

are trade marks
trade marks.

#189222

Cutter and print to cut
Pantone 286

Ink sequence to reflect order of Repro trapping
based on luminosity of inks (lightest to darkest)

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)